Biotin anti-mouse TER-119/Erythroid Cells Antibody

Pricing & Availability
Clone
TER-119 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-76
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
TER-119_Biotin_TER-119_Antibody_FC_041713
C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
  • TER-119_Biotin_TER-119_Antibody_FC_041713
    C57BL/6 bone marrow cells were stained with biotinylated TER-119 (filled histogram) or biotinylated rat IgG2b, κ isotype control (open histogram) and then detected with Sav-PE.
Compare all formats
Cat # Size Price Quantity Check Availability Save
116203 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
116204 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The TER-119 antigen is a 52 kD glycophorin A-associated protein, also known as Ly-76. TER-119 is an erythroid-specific antigen expressed on early proerythroblasts to mature erythrocytes, but not on erythroid colony-forming cells (BFU-E, blast-forming unit erythroid, or CFU-E, colony-forming unit erythroid).

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  2. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  3. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  4. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  5. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  6. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  7. Geiger SS, et al. 2021. Nature Communications. 12(1):2745. PubMed
  8. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  9. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  10. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  11. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  12. Wu J, et al. 2022. Nat Commun. 13:7321. PubMed
  13. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  14. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  15. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  16. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  17. Tian M, et al. 2020. Proc Natl Acad Sci U S A. 117:7929. PubMed
  18. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  19. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  20. Krueger PD, et al. 2021. Immunity. 54(4):687-701.e4. PubMed
  21. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  22. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  23. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  24. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  25. Iturri L, et al. 2021. Immunity. . PubMed
  26. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  27. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  28. Fu R, et al. 2019. Nat Commun. 10:3210. PubMed
  29. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  30. Hodzic D, et al. 2022. PLoS Biol. 20:e3001811. PubMed
  31. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  32. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  33. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  34. Verena Sigl et al. 2017. Cell research. 26(7):761-74 . PubMed
  35. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  36. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  37. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  38. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  39. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  40. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  41. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  42. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  43. Liu YY, et al. 2020. Chin Med J (Engl). 133:1688. PubMed
  44. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  45. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  46. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  47. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  48. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  49. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  50. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  51. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  52. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  53. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  54. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  55. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  56. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  57. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  58. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  59. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  60. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  61. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  62. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  63. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  64. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  65. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  66. Chatterjee S, et al. 2014. PLoS One. 9:87858. PubMed
  67. Ludwik KA, et al. 2021. STAR Protocols. 2(1):100270. PubMed
  68. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  69. Peraki I, Palis J, and Mavrothalassitis G. 2017. Mol Cell Biol. 10.1128/MCB.00183-17. PubMed
  70. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  71. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  72. Dong S, et al. 2021. Nature. 591:117. PubMed
  73. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  74. Zhu H, et al. 2020. J Bone Miner Res. 35:698. PubMed
  75. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  76. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  77. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  78. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  79. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  80. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  81. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  82. Sitaraman S, et al. 2019. Sci Rep. 9:12509. PubMed
  83. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  84. Lüönd F, et al. 2022. STAR Protoc. 3:101438. PubMed
  85. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  86. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  87. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  88. Wang C, et al. 2018. J Clin Invest. 128:3872. PubMed
  89. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  90. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  91. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  92. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  93. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  94. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  95. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  96. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  97. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  98. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  99. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  100. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  101. Bagadia P, et al. 2019. Nat Immunol. 20:1174. PubMed
  102. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  103. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  104. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  105. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  106. Gu VW, et al. 2021. Stem Cell Reports. 16:106. PubMed
  107. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  108. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  109. Alexander K, et al. 2016. Immunol Cell Biol. 95:7-16. PubMed
  110. Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed
  111. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  112. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  113. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  114. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  115. Buffolo M, et al. 2019. Cell Rep. 29:270. PubMed
  116. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  117. Hasenberg M, et al. 2011. PLoS One. 6:e17314. PubMed
  118. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  119. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  120. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  121. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  122. Wolock SL, et al. 2019. Cell Rep. 28:302. PubMed
  123. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  124. Koide S, et al. 2022. iScience. 25:103603. PubMed
  125. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  126. Michel A, et al. 2013. J Immunol. 90:5534. PubMed
  127. Lefkopoulos S, et al. 2020. Immunity. 53(5):934-951.e9. PubMed
  128. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  129. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  130. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  131. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  132. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  133. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  134. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  135. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  136. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  137. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  138. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  139. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  140. Huang X, et al. 2021. Immunity. . PubMed
  141. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  142. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  143. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  144. Young K, et al. 2021. Cell Stem Cell. . PubMed
  145. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  146. Seong J, et al. 2018. Development. 145:14. PubMed
  147. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  148. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  149. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  150. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
RRID
AB_313704 (BioLegend Cat. No. 116203)
AB_313705 (BioLegend Cat. No. 116204)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID
UniProt
View information about TER-119 on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All TER-119 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse TER-119/Erythroid Cells TER-119 FC
Biotin anti-mouse TER-119/Erythroid Cells TER-119 FC
FITC anti-mouse TER-119/Erythroid Cells TER-119 FC
PE anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells TER-119 FC, IHC-F, IHC-P, IP, WB
Alexa Fluor® 488 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 647 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 700 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP/Cyanine5.5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 421™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Pacific Blue™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 650™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 510™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 605™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells (Maxpar® Ready) TER-119 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 785™ anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-A0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
APC/Fire™ 750 anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-B0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
TotalSeq™-C0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
Ultra-LEAF™ Purified anti-mouse TER-119/Erythroid Cells TER-119 FC, IHC-F, IHC-P, IP, WB, CMCD
Spark Blue™ 550 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Fire™ 810 anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark NIR™ 685 anti-mouse TER-119/Erythroid Cells Antibody TER-119 FC
Go To Top Version: 3    Revision Date: 12-04-2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse TER-119/Erythroid Cells

  • Biotin anti-mouse TER-119/Erythroid Cells

  • FITC anti-mouse TER-119/Erythroid Cells

  • PE anti-mouse TER-119/Erythroid Cells

  • PE/Cyanine5 anti-mouse TER-119/Erythroid Cells

  • Purified anti-mouse TER-119/Erythroid Cells

  • Alexa Fluor® 488 anti-mouse TER-119/Erythroid Cells

  • Alexa Fluor® 647 anti-mouse TER-119/Erythroid Cells

  • Alexa Fluor® 700 anti-mouse TER-119/Erythroid Cells

  • PE/Cyanine7 anti-mouse TER-119/Erythroid Cells

  • APC/Cyanine7 anti-mouse TER-119/Erythroid Cells

  • PerCP anti-mouse TER-119/Erythroid Cells

  • PerCP/Cyanine5.5 anti-mouse TER-119/Erythroid Cells

  • Brilliant Violet 421™ anti-mouse TER-119/Erythroid Cells

  • Pacific Blue™ anti-mouse TER-119/Erythroid Cells

  • Brilliant Violet 650™ anti-mouse TER-119/Erythroid Cells

  • Brilliant Violet 510™ anti-mouse TER-119/Erythroid Cells

  • Brilliant Violet 605™ anti-mouse TER-119/Erythroid Cells

  • Purified anti-mouse TER-119/Erythroid Cells (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse TER-119/Erythroid Cells

  • Brilliant Violet 785™ anti-mouse TER-119/Erythroid Cells

  • TotalSeq™-A0122 anti-mouse TER-119/Erythroid Cells

  • APC/Fire™ 750 anti-mouse TER-119/Erythroid Cells

  • TotalSeq™-B0122 anti-mouse TER-119/Erythroid Cells

  • TotalSeq™-C0122 anti-mouse TER-119/Erythroid Cells

  • Ultra-LEAF™ Purified anti-mouse TER-119/Erythroid Cells

  • Spark Blue™ 550 anti-mouse TER-119/Erythroid Cells

  • APC/Fire™ 810 anti-mouse TER-119/Erythroid Cells

  • Spark NIR™ 685 anti-mouse TER-119/Erythroid Cells Antibody

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account